+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 6Years - 17Years
All Genders
ID04649242

Phase 3 Randomized Trial Evaluating Safety and Efficacy of Rimegepant for Acute Migraine Treatment in Children and Adolescents Aged 6 to Under 18 Years

Led by Pfizer · Updated on 2026-10-27

2100

Participants Needed

246

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of BHV-3000 rimegepant compared to a placebo for treating moderate or severe migraine attacks in children and adolescents aged 6 to under 18 years. This Phase 3 study focuses on acute treatment for pediatric migraine, including cases with or without aura, aiming to better understand how well rimegepant relieves migraine pain and associated symptoms shortly after dosing. Participants are randomly assigned to receive either BHV-3000 at doses of 75 mg or 50 mg orally disintegrating tablet ODT or a matching placebo tablet. The study uses a triple-blind design to compare outcomes between these groups. The trial includes children and adolescents who experience 1 to 8 moderate or severe migraine attacks monthly, with attacks lasting over 3 hours. Some participants may continue stable preventive migraine medications except CGRP antagonists. The study monitors patients during the acute migraine attack treatment phase. During the study, participants will be assessed for pain freedom two hours after dosing as the primary outcome, as well as secondary outcomes such as freedom from the most bothersome migraine symptoms, need for rescue medication within 24 to 48 hours, sustained pain freedom, and ability to function normally. Safety and efficacy data will be collected throughout. The total duration of participation varies depending on individual treatment and follow-up requirements, with the primary completion planned by January 2029.

CONDITIONS

Brief Title

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Research Team

P

Pfizer Pfizer CT.gov Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here